Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis

References

• MendozaMMandaniGMomandJThe MDM2 gene familyBiomol Concepts20145191925372739
   PubMedGoogle Scholar
• BondGLHuWBondEEA single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humansCell2004119559160215550242
   PubMed Web of Science ®Google Scholar
• WeiJYangYLuMEscape, or vanish: control the fate of p53 through MDM2-mediated ubiquitinationAnticancer Agents Med Chem201516217418926343143
   PubMed Web of Science ®Google Scholar
• AlmquistLMKaragasMRChristensenBCThe role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancerCarcinogenesis201132332733021123835
   PubMed Web of Science ®Google Scholar
• ZhangQZengSXLuHTargeting p53-MDM2-MDMX loop for cancer therapySubcell Biochem20148528131925201201
   PubMedGoogle Scholar
• RajendranVStructural analysis of oncogenic mutation of isocitrate dehydrogenase 1Mol Biosyst20161272276228727194485
   PubMedGoogle Scholar
• KumarARajendranVSethumadhavanRPurohitRIn silico prediction of a disease-associated STIL mutant and its affect on the recruitment of centromere protein J (CENPJ)FEBS Open Bio20122285293
   PubMed Web of Science ®Google Scholar
• KumarAPurohitRComputational screening and molecular dynamics simulation of disease associated nsSNPs in CENP-EMutat Res2012738–7392837
   PubMed Web of Science ®Google Scholar
• KamarajBRajendranVSethumadhavanRKumarCVPurohitRMutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6J Biomol Struct Dyn201533483484424738488
   PubMed Web of Science ®Google Scholar
• PurohitRRole of ELA region in auto-activation of mutant KIT receptor: a molecular dynamics simulation insightJ Biomol Struct Dyn20143271033104623782055
   PubMed Web of Science ®Google Scholar
• KumarAPurohitRUse of long term molecular dynamics simulation in predicting cancer associated SNPsPLoS Comput Biol2014104e100331824722014
   PubMed Web of Science ®Google Scholar
• ZhangLZhuZWuHWangKAssociation between SNP309 and del1518 polymorphism in MDM2 homologue and esophageal squamous cell carcinoma risk in Chinese population of Shandong ProvinceAnn Clin Lab Sci201545443343726275695
   PubMed Web of Science ®Google Scholar
• ChenXSturgisEMLeiDDahlstromKWeiQLiGHuman papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinomaCancer Res201070187199720820736372
   PubMed Web of Science ®Google Scholar
• XieLSunYChenTAssociation between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysisOnco Targets Ther201583679369026672516
   PubMed Web of Science ®Google Scholar
• QiuMLiuYYuXInteraction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinomaTumour Biol20163733863387026476535
   PubMedGoogle Scholar
• McGrawKLCluzeauTSallmanDATP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromesOncotarget2015633344373444526416416
   PubMedGoogle Scholar
• HeXChenPYangKAssociation of MDM2 polymorphism with risk and prognosis of leukemia: a meta-analysisActa Haematol2015133436537125790771
   PubMed Web of Science ®Google Scholar
• MisraCMajumderMBajajSGhoshSRoyBRoychoudhurySPolymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancerMol Carcinog200948979080019204927
   PubMed Web of Science ®Google Scholar
• MaKCaoBGuoMThe detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaClin Epigenetics201684327110300
   PubMed Web of Science ®Google Scholar
• KumarSShahJPBryantCSPrognostic significance of keratinization in squamous cell cancer of uterine cervix: a population based studyArch Gynecol Obstet20092801253219043726
   PubMed Web of Science ®Google Scholar
• MarurSForastiereAAHead and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatmentMayo Clin Proc201691338639626944243
   PubMed Web of Science ®Google Scholar
• StratigosAGarbeCLebbeCDiagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineEur J Cancer201551141989200726219687
   PubMed Web of Science ®Google Scholar
• DermanBAMilehamKFBonomiPDBatusMFidlerMJTreatment of advanced squamous cell carcinoma of the lung: a reviewTransl Lung Cancer Res20154552453226629421
   PubMed Web of Science ®Google Scholar
• ZhouJLiuFZhangDSignificance of MDM2-309 polymorphisms and induced corresponding plasma MDM2 levels in susceptibility to laryngeal squamous cell carcinomaDNA Cell Biol2014332889424325471
   PubMed Web of Science ®Google Scholar
• HamidSYangYHPengKNMDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onsetOral Oncol200945649650018804411
   PubMed Web of Science ®Google Scholar
• LiuJZhengYLeiDMDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysisAsian Pac J Cancer Prev20111281899190322292622
   PubMedGoogle Scholar
• XieJLYangJLLiuDSXieYGJiPImpact of MDM2 single nucleotide polymorphism on oral squamous cell carcinoma riskCell Biochem Biophys201571299399825323564
   PubMed Web of Science ®Google Scholar
• ChenBXiongMMMengXLCurrent evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibilityDis Esophagus201528659360124844868
   PubMed Web of Science ®Google Scholar
• YangJLiuBLiWAssociation of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC)Cancer Epidemiol201337562963323837945
   PubMed Web of Science ®Google Scholar
• ErLMZhangLWNieWWRelevance of MDM2 polymorphisms with esophageal squamous cell carcinoma, gastric adenocarcinoma and double primary cancers in esophagus and stomachZhonghua Yu Fang Yi Xue Hui2012391333423344
   Google Scholar
• AlhopuroPYlisaukko-OjaSKKoskinenWJThe MDM2 promoter polymorphism SNP309T–>G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neckJ Med Genet200542969469816141004
   PubMed Web of Science ®Google Scholar
• RoszakAMisztalMSowińskaAJagodzińskiPPMurine double-minute 2 homolog single nucleotide polymorphisms 285 and 309 in cervical carcinogenesisMol Diagn Ther201519423524426224627
   PubMed Web of Science ®Google Scholar
• HongYMiaoXZhangXThe role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinomaCancer Res200565209582958716230424
   PubMed Web of Science ®Google Scholar
• LiuGWheatley-PricePZhouWGenetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer riskInt J Cancer2008122491591817957785
   PubMed Web of Science ®Google Scholar
• TuHFChenHWKaoSYLinSCLiuCJChangKWMDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiationRadiother Oncol200887224325218423915
   PubMed Web of Science ®Google Scholar
• ParkSHChoiJEKimEJMDM2 309T>G polymorphism and risk of lung cancer in a Korean populationLung Cancer2006541192416876289
   PubMed Web of Science ®Google Scholar
• NakashimaMKondoSShimizuYImpact of MDM2 single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinomaActa Otolaryngol2008128780881318568525
   PubMed Web of Science ®Google Scholar
• LoginovVIAtkarskaiaMVBurdennyĭAMAssociation of Arg72Pro of TP53 and T309G of MDM2 genes polymorphisms with non-small-cell lung cancer in Russians of the Moscow regionMol Biol (Mosk)20144815257 Russian
   Web of Science ®Google Scholar
• JiangPLiuJWLiWZengXXTangJXCorrelation between MDM2 gene SNP309 polymorphisms and cervical cancerClin Oncol Cancer Res201138114
   Google Scholar
• HuangSFChenIHLiaoCTWangHMLiouSHHsiehLLCombined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewingOral Oncol2009451162218487080
   PubMed Web of Science ®Google Scholar
• YuHHuangYJLiuZEffects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neckMol Carcinog201150969770621656578
   PubMed Web of Science ®Google Scholar
• MaJZhangJNingTChenZXuCAssociation of genetic polymorphisms in MDM2, PTEN and P53 with risk of esophageal squamous cell carcinomaJ Hum Genet201257426126422336889
   PubMed Web of Science ®Google Scholar
• CaoYYZhangXFGuoWWangRHui GeHZhangJHAssociation of the MDM2 polymorphisms with susceptibility of esophageal squamous cell carcinoma and that of gastric cardiac adenocarcinomaTumor2007278628632
   Google Scholar
• KohnoTKunitohHMimakiSContribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinomaJ Thorac Oncol20116481381721623257
   PubMed Web of Science ®Google Scholar
• SinghalPHussainSThakurNAssociation of MDM2 and p53 polymorphisms with the advancement of cervical carcinomaDNA Cell Biol2013321192723210739
   PubMed Web of Science ®Google Scholar
• LiRZhangLLiuZCorrelation of MDM2 gene polymorphisms and risk of esophageal squamous cell carcinoma in south-west Shandong Han nationalityJ Xinxiang Med Coll2011284437439
   Google Scholar
• NanHQureshiAAHunterDJHanJA functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancerCancer Causes Control200920217117918814047
   PubMed Web of Science ®Google Scholar
• ZhangXMMiaoXPGuoYLGenetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancerHum Mutat200627111011716287156
   PubMed Web of Science ®Google Scholar
• BondGLHuWLevineAA single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effectCancer Res200565135481548415994915
   PubMed Web of Science ®Google Scholar
• HuZJinGWangLChenFWangXShenHMDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: evidence from 21 case-control studiesCancer Epidemiol Biomarkers Prev200716122717272318086778
   PubMed Web of Science ®Google Scholar
• ChenBCaoLHuKWZhangJWMengXLXiongMMMDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancersTumour Biol20143543431343824338709
   PubMedGoogle Scholar
• LiuGCesconDWZhaiRp53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinomaDis Esophagus2010231363919302219
   PubMed Web of Science ®Google Scholar
• ChenJYYangHWenJAssociation between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysisDis Esophagus Epub2015415
   Web of Science ®Google Scholar
• VlatkovićNEl-FertADevlingTLoss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neckCancer2011117132939295021692053
   PubMed Web of Science ®Google Scholar